Skip to main content
. 2015 May 6;92(5):952–958. doi: 10.4269/ajtmh.14-0346

Table 1.

Baseline and posttreatment prevalences of demographic traits and findings

Type Trait Baseline (N = 201) Posttreatment (N = 180)
n N % n N %
Age < 2.5 years 32 198 16.2 7 180 3.9
2.5 years ≤ age < 4 years 89 198 44.9 79 180 43.9
Age ≥ 4 years 69 198 34.8 88 180 48.9
Unable to confirm 8 198 4.0 6 180 3.3
Schistosomiasis-infected 159 198 80.3
Infection status Egg−/Ab+ 70 198 35.4
Egg+ 89 198 44.9 62 180 34.4
Egg+, Ab+ 80 198 40.4
Egg+, Ab– 9 198 4.5
Light intensity (< 100 EPG*) 41 198 20.7 34 180 18.9
Medium intensity (100–400 EPG) 28 198 14.1 19 180 10.6
Heavy intensity (> 400 EPG) 20 198 10.1 9 180 5.0
Malaria (Smear) 7 198 3.5 (Smear) 30 180 16.7
(RDT) 70 180 38.9
Hepatitis B (surface antigen) 2 190 1.1
Liver pattern Liver IPB 30 200 15.0 36 180 20.0
Morbidities Anemia 161 196 82.1 106 173 61.3
Undernutrition* 44 182 24.2 39 166 23.5
Left lobe hepatomegaly 91 182 50.0 99 152 65.1
Right-lobe atrophy 3 177 1.7 1 149 0.7
Splenomegaly 54 185 29.2 66 158 41.8
Serum findings Elevated AST (> 37 units/L) 155 180 86.1
Mild (< 148 units/L) 154 180 85.6
Moderate/severe (≥ 148 units/L) 1 180 0.1
Elevated ALT (> 42 units/L) 3 180 1.7
Elevated bilirubin (> 17 μmol/L) 4 180 2.2

ALT = alanine aminotransferase; AST = aspartine aminotransferase; EPG = eggs per gram; IPB = image pattern B.

*

Undernutrition = weight for age, height for age, or weight for height < −2 standard deviations below mean (WHO).

Organomegaly = span > 2 standard deviations above mean for height as determined by Yazadanpanah and others.